[ACTH treatment of multiple sclerosis]. 1966

K Boman, and E Hokkanen, and L Jarho, and E Kivalo

UI MeSH Term Description Entries
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000324 Adrenocorticotropic Hormone An anterior pituitary hormone that stimulates the ADRENAL CORTEX and its production of CORTICOSTEROIDS. ACTH is a 39-amino acid polypeptide of which the N-terminal 24-amino acid segment is identical in all species and contains the adrenocorticotrophic activity. Upon further tissue-specific processing, ACTH can yield ALPHA-MSH and corticotrophin-like intermediate lobe peptide (CLIP). ACTH,Adrenocorticotropin,Corticotropin,1-39 ACTH,ACTH (1-39),Adrenocorticotrophic Hormone,Corticotrophin,Corticotrophin (1-39),Corticotropin (1-39),Hormone, Adrenocorticotrophic,Hormone, Adrenocorticotropic
D026741 Physical Therapy Modalities Therapeutic modalities frequently used in PHYSICAL THERAPY SPECIALTY by PHYSICAL THERAPISTS or physiotherapists to promote, maintain, or restore the physical and physiological well-being of an individual. Physical Therapy,Physiotherapy (Techniques),Group Physiotherapy,Neurological Physiotherapy,Neurophysiotherapy,Physical Therapy Techniques,Group Physiotherapies,Modalities, Physical Therapy,Modality, Physical Therapy,Physical Therapies,Physical Therapy Modality,Physical Therapy Technique,Physiotherapies (Techniques),Physiotherapies, Group,Physiotherapy, Group,Physiotherapy, Neurological,Techniques, Physical Therapy,Therapy, Physical

Related Publications

K Boman, and E Hokkanen, and L Jarho, and E Kivalo
November 1961, Zeitschrift fur arztliche Fortbildung,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
April 1950, Nordisk medicin,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
January 1967, Bollettino - Societa medico chirurgica Cremona,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
February 1966, Minnesota medicine,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
September 1965, Schweizerische medizinische Wochenschrift,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
August 1963, Munchener medizinische Wochenschrift (1950),
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
January 1965, Acta neurologica Scandinavica. Supplementum,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
January 1955, Revue neurologique,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
January 1953, Acta psychiatrica et neurologica Scandinavica,
K Boman, and E Hokkanen, and L Jarho, and E Kivalo
July 1961, Das Deutsche Gesundheitswesen,
Copied contents to your clipboard!